Ann Van Landschoot

Title: Ann Van Landschoot: Innovator in Cancer and Neurological Disorder Research

Introduction

Ann Van Landschoot is a prominent inventor based in Deftinge, Belgium. She has made significant contributions to the field of drug discovery, particularly in relation to cancer and neurological disorders. Her innovative work has led to the development of a patent that provides valuable insights into protein interactions that are crucial for understanding cell growth and development.

Latest Patents

Ann Van Landschoot holds a patent for "CDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation." This invention is pivotal in the realms of drug discovery, diagnosis, prognosis, and treatment of cancer and neurological disorders. It offers access to and insight into protein-protein or protein-DNA interactions within signal transduction or transcriptional pathways. The invention provides essential means, such as nucleic acids, proteins, cells, and experimental animals, to identify candidate drugs for therapeutic use in treating these serious conditions.

Career Highlights

Throughout her career, Ann has been associated with the Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw, where she has collaborated with other notable researchers. Her work has been instrumental in advancing the understanding of intracellular signaling and gene regulation, particularly through her research on alpha-catenin-binding proteins.

Collaborations

Ann has worked alongside esteemed colleagues such as Frans Van Roy and Barbara Janssens. Their collaborative efforts have further enriched the research landscape in biotechnology and drug discovery.

Conclusion

Ann Van Landschoot's contributions to the field of biotechnology and her innovative patent highlight her role as a key figure in the fight against cancer and neurological disorders. Her work continues to inspire advancements in drug discovery and therapeutic strategies.